瀏覽其他金融產品

INCYINCYIncyte Corporation
INCY

Incyte Corporation

INCY
$97.07
+0.00% (24h)
股票級別 C1000x 槓桿

重點摘要

最後更新: 2026-09-28
  • •Atebrioz 獲得 FDA 核准是一項「regulation_final」事件 — 二元風險已完全消除,焦點轉向商業執行。
  • •H.C. Wainwright 在獲准後調升目標價,顯示分析師對英賽特新藥的營收前景有信心。
  • •英賽特併購策略(Star Therapeutics、Vega Therapeutics)提供了多元產品線,支持更高的估值倍數。
  • •XBI 和 IBB 可能會因英賽特消息而出現邊際上的正面類股情緒,但 INCY 的個別影響佔主導地位。
  • •第二季財測未達標的顧慮,可能因 Atebrioz 的獲准而部分抵銷,改善了 INCY 差價合約 (CFD) 多頭的中期風險/報酬比。

價格及市場結構

加載圖表中...

市況形態狀態

槓桿倍數
1000x
(CoinUnited.io 最高)
波動性
N/A

術語表

關鍵上市股票與 CFD 詞彙,每個一句 —— 令頁面對讀者同 AI 引擎都清晰無歧義。

股票差價合約針對股價的差價合約 —— 僅取得價格敞口,並不擁有相關股份。
延長時段在交易所常規時段以外的盤前及盤後交易。
基差風險差價合約參考價與交易所成交價未必同步變動的風險。
市盈率市盈率 = 股價 ÷ 每股盈利;常用的估值指標。
毛利率毛利 ÷ 營收;反映產品層面的盈利能力。
每股盈利每股盈利 = 淨利潤 ÷ 攤薄後流通股數。

最新動態

2026-09-28股票看漲
INCY

H.C. Wainwright 提高英賽特目標價,因 Atebrioz 獲 FDA 核准

H.C. Wainwright 在美國食品藥物管理局 (FDA) 核准 Atebrioz 後,已調升英賽特公司 (Incyte Corporation, INCY) 的目標價,這標誌著該公司的一項重要監管里程碑。雖然本次報告無法取得研究數據饋送,但訊號分類為 `regulation_final` 並帶有看漲方向標籤,證實這是一項已完成的監管決策,而非待定的催化劑,這對交易者而言,顯著改變了風險計算

2026-07-28股票波動
INCY

Incyte Q2 Earnings Smash: $3.09 EPS Beats by $0.94, But Guidance Miss Creates a Two-Sided CFD Trade

Incyte Corporation (NASDAQ: INCY) reported Q2 non-GAAP EPS of $3.09, beating consensus estimates by approximately $0.94, and revenue of $1.67 billion, surpassing analyst expectations by roughly $180 m

2026-06-08股票波動
INCY

Incyte Acquires Vega Therapeutics for $1.25B — Hematology Bet Deepens Biotech M&A Wave

Incyte Corporation (NASDAQ: INCY) has announced the acquisition of Vega Therapeutics, a privately held hematology-focused biotech developed within the Star Therapeutics company-creation platform, for

2026-06-07股票波動
INCY

Incyte 約 20 億美元收購 Star Therapeutics:槓桿情境與生技併購解讀

根據《金融時報》報導,Incyte Corporation (INCY) 即將以約 20 億美元的價格收購一家私營血液疾病藥物開發商 Star Therapeutics。此交易尚未獲得雙方公司正式確認,但《金融時報》的消息來源 — 通常基於熟悉內情人士 — 在事件驅動型市場中被視為高度可信。Star Therapeutics 專注於血液學/罕見血液疾病,與 Incyte 現有的腫瘤學和血液學業務相

Get Started with Incyte Corporation

Start trading Incyte Corporation on CoinUnited.io with industry-leading leverage and fees that drop to 0% at the top VIP tier.

Trade with Leverage

Trade INCY CFDs with up to 1000x leverage on CoinUnited.io.

  • Up to 1000x leverage
  • Fees down to 0%
  • Advanced risk management tools
Trade INCY Now

Explore Stocks

Browse the full stocks market on CoinUnited.io with 125+ instruments.

  • 125+ stocks instruments
  • Real-time market data
  • Professional charting tools
Browse Stocks

Learn Stocks Trading

Read our in-depth research and analysis on stocks markets.

  • Expert market analysis
  • Technical analysis basics
  • Daily market insights
Read Our Research

How to Trade Incyte Corporation: Step-by-Step Guide

Learn how to trade Incyte Corporation (INCY) on CoinUnited.io with up to 1000x leverageand volume-tiered fees that reach 0% at the top VIP level. Follow this simple step-by-step guide to start CFD trading today.

1

Create Your CoinUnited.io Account

Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.

  • ✓Quick and free registration
  • ✓Email and password setup
  • ✓Two-factor authentication for security
2

Verify Your Identity

Complete the KYC verification process to unlock full trading features and higher limits.

  • ✓Upload government-issued ID
  • ✓Proof of address document
  • ✓Usually verified within minutes
3

Deposit Funds

Fund your account using one of the supported deposit methods.

Deposit Methods

  • •Cryptocurrency deposits (BTC, ETH, USDT)
  • •Bank transfer available
  • •No minimum deposit requirement
4

Find INCY in the Stocks Section

Navigate to the stocks market section and search for INCY. You can trade Incyte Corporation as a CFD with up to 1000x leverage.

  • ✓Search for "INCY" in the trading platform
  • ✓Select CFD trading mode
  • ✓Review the current price and market data
5

Place Your Trade

Choose your position direction (long or short), set your leverage, and enter your position size to trade Incyte Corporation.

  • ✓Long (buy) if you expect INCY to rise
  • ✓Short (sell) if you expect INCY to fall
  • ✓Set stop-loss and take-profit levels
6

Monitor & Manage Risk

Keep track of your open positions and manage risk with stop-loss orders and position sizing.

  • ✓Monitor P&L in real-time
  • ✓Adjust stop-loss as needed
  • ✓Never risk more than you can afford to lose

Order Types

Market Order

Execute immediately at the current market price. Best for quick entries.

Limit Order

Set a specific price to enter. The order fills only when the market reaches your price.

Stop-Loss Order

Automatically close your position at a specified price to limit potential losses.

Important Tips

  • • Start with a small position to understand how leverage works
  • • Always set a stop-loss to protect your capital
  • • Higher leverage amplifies both gains and losses
  • • Never invest more than you can afford to lose

準備交易 Incyte Corporation 了嗎?

最高 1000x 槓桿

立即交易 INCY

代號

INCY

市場

股票

板塊

General

CU 產品代碼

INCY

標籤

Enterprise Strategic Partnership WaveEnterprise Partnership Deal RepricingPost War Energy Tech Partnership SurgeMulti Jurisdiction Crypto Regulatory TighteningCrypto Exchange Acquisition WaveDEFI Fintech Product Launch WaveCrypto Media Regulatory EnforcementGlobal Crypto Equity Regulation WaveDEFI Flash Loan Exploit WaveMega Contract Partnership Repricing

Similar Stocks Assets

Explore other stocks instruments in the same sector as Incyte Corporation. Compare performance and find trading opportunities.

JBL

Jabil Inc.

$288.37
▼9.5%
ZETA

Zeta Global Holdings Corp.

$31.68
▲9.5%
Z

ProShares UltraShort Silver

$24.60
▲8.5%
TRU

TransUnion

$64.23
▼6.5%
CAG

ConAgra Brands, Inc.

$13.36
▼5.4%

關於作者

CoinUnited.io 研究團隊

本頁由 CoinUnited.io 研究團隊整理:專責上市股票及全球市場的分析師,以一手申報文件及具名第三方數據為依據,而非意見推論。

我們的研究方法

每項數據均可追溯至一手或具名第三方來源並標註日期:財務報表取自公司的 SEC 申報文件,機構持股取自 Form 13F,分析師目標價取自聚合的第三方研究,市場數據取自 CoinUnited 參考價。本頁的出處對照表逐項列出來源,以及我們最後一次查核的日期。

免責聲明:內容僅供資訊及教育用途,並非個人化財務建議。股票差價合約風險重大,只提供價格敞口,並非股權擁有。請自行研究並諮詢合資格財務顧問。

免責聲明與參考資料

重要風險提示

CoinUnited 股票差價合約只提供 Incyte Corporation 的價格敞口,並非股權擁有:沒有股東投票權、沒有股息,亦不會以相關股票交收。

槓桿同時放大虧損與盈利,部位可能在相關股價回升之前已被強制平倉。相關股票按交易所時段掛牌,參考價可能在時段之間跳空。

用戶在作出任何投資決策前,應自行研究並諮詢合資格的財務專業人士。本平台之創建者及營運者概不承擔因依賴相關資訊而導致的任何財務損失或其他損害責任。

槓桿交易風險極高,可能損失全部本金。

方法論概覽

本頁數據來自一手及具名第三方來源,並非由預測模型產生。每一項的來源與日期均列於上方的出處對照表。

  • 財務報表:公司自身的 SEC 申報文件(10-K/10-Q),由 XBRL 讀取
  • 市場數據:CoinUnited 參考價及每日收市價
  • 機構持股:SEC Form 13F 季度申報
  • 分析師目標價:聚合的第三方賣方研究 — 屬第三方意見,並非 CoinUnited 觀點
  • 同業倍數:第三方過去十二個月比率

CoinUnited 不會就 Incyte Corporation 發布價格預測或目標價。

方法論最後審閱日期:

準備好開始交易 Incyte Corporation 了嗎?

加入數千名交易者,今天就開始您的 Incyte Corporation 交易之旅。獲得先進的交易工具和具競爭力的費用。